Table 2 Hospital admission data and risk factors for patients with candidemia (N = 115)
From: Evaluation of Candida bloodstream infection and antifungal utilization in a tertiary care hospital
Variables | Descriptions |
|---|---|
Sex n(%) | |
Female | 44 (38.3) |
Male | 71 (61.7) |
Age (years) | |
Mean (SD) | 68 (17.9) |
Median (1st quartile - 3rd quartile) | 70 [56–84] |
Minimum maximum | 26–100 |
Length of stay (days) | |
Mean (SD) | 69.8 (138.4) |
Median (1st quartile - 3rd quartile) | 36 [21–62.5] |
Minimum maximum | 1–1003 |
Use of antimicrobial | 113 (98.3) |
Use of chemotherapy drugs | 12 (10.4) |
Use of corticosteroids | 95 (82.6) |
Use of parenteral nutrition | 46 (40.0) |
Presence of some type of central venous catheter | 86 (74.8) |
Had any type of surgery | 79 (68.7) |
Admission to the intensive care unit | 94 (81.7) |
Length of ICU stay (days) (n = 94) | |
Mean (SD) | 23.3 (23.3) |
Median (1st quartile - 3rd quartile) | 15 (6–32) |
Minimum maximum | 1–100 |
Neutropenia | 6 (5.2) |
Use of vasoactive drug | 86 (74.8) |
Use of mechanical ventilation | 82 (71.3) |
Hemodialysis | 38 (33.0) |
Had hemotherapy | 27 (23.5) |
Positive blood culture even when using antifungal therapy | 35 (30.4) |
Clinical outcome | |
Discharge from hospital | 56 (48.7) |
In-hospital mortality | 59 (51.3) |